<p><strong>&#160;</strong></p>
<p>Phthalic acid esters (PAEs) and polycyclic aromatic hydrocarbons (PAHs) are classified as priority pollutants by United States Environment Protection Agency (USEPA). Some of the PAEs and PAHs are considered as human carcinogens by International Agency for Research on Cancer (IARC). In the present study, an ultra-high performance liquid chromatography coupled to triple quadruple mass spectrometry (LC-MS QQQ) method was developed and validated for the simultaneous determination of PAEs and PAHs bound to ambient particulate matter. After the method validation, it was deployed for the quantification of PAEs and PAHs bound to PM<sub>2.5</sub> collected at a sub urban site in the Northwest Indo-Gangetic Plain. The targeted PAEs in this study are dimethyl phthalate (DMP), diethyl phthalate (DEP), benzyl butyl phthalate (BBP), di butyl phthalate (DBP), bis (2-ethyl hexyl) phthalate (DEHP), bis (2-ethylhexyl) adipate (DEHA), di-n-octyl phthalate (DNOP) and PAHs are benzo[a]anthracene (B[a]A), benzo[b]fluorenthene (B[b]F), benzo[k]fluorenthene (B[k]F), benzo[a]pyrene (B[a]P), dibenzo[ah]anthracene (D[ah]A), benzo[ghi]perylene (B[ghi]P), and indeno[1,2,3-cd]pyrene (IND). The measured concentrations of PAEs and PAHs are seasonally varied and the higher concentrations of PAEs were observed in summer and PAHs in winter. DEHP (17.94 ng m<sup>-3</sup>) and B[b]F (36.13 ng m<sup>-3</sup>) are the most abundant PAE and PAH measured at the sampling site. The concentrations of B[a]P (4.66 ng m<sup>-3</sup>; Group 1 carcinogen) exceeded the threshold limits (1 ng m<sup>-3</sup>) set by the National Ambient Air Quality Standards of India (NAAQS). Further, the incremental lifetime cancer risk due to inhalation exposure to DEHP and B[a]P were estimated for adults (0.3678 &#215; 10<sup>-6</sup> and 1.40 &#215; 10<sup>-5</sup> respectively) and children (0.8792 &#215; 10<sup>-6</sup> and 3.272 &#215; 10<sup>-5</sup> respectively). Also, the cancer risk associated with the inhalation exposure to B[a]P has exceeded the limits (1 &#215;10<sup>-3</sup>) set by USEPA at the measurement site.</p>
Neem tree (Azadirachta indica) is one of the richest sources of
secondary metabolites. More than 250 natural products have been
characterized from various parts of the neem tree. These include
diterpenoids, triterpenoids, steroids, flavonoids, coumarins, hydrocarbons,
and fatty acids. Many of these products possess therapeutic properties. Neem
exudate or toddy is a milky white liquid with a strong smell secreted from
the angle between the 2 main branches of old trees. Profiling of neem toddy
for the presence of active metabolites was done by an in-house database
using UHPLC-QTOF-MS. Fifty-seven metabolites were identified from the full
scan of electrospray ionization positive and negative mode from the neem
toddy extract by using UHPLC-QTOF-MS. Further confirmation of 31 of these
metabolites was done by obtaining MS/MS spectrum from UHPLC-QTOF-MS.
Principal component analysis study of metabolites from neem toddy with
leaves, seed, seed coat, and bark revealed that they are closely related to
those contained in neem seeds and seed coats. Azadirachtin, nimbidiol,
22,23-dihydroazadirachtin, nimbonone, nimbonolone, nimosone, and
6-deacetylnimbinene were found to be some of the most abundant metabolites
in neem toddy. The neem toddy extract showed significant anti-inflammatory
activity when tested in N9 murine microglial cells with 25 ng of recombinant
mouse tumor necrosis factor alpha protein (active) using qRT-PCR. The active
metabolites in neem toddy could be further explored for their therapeutic
potentials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.